Polomar Health Services (PMHS) Market Capitalization (2022 - 2026)
Polomar Health Services (PMHS) posted Market Capitalization of $3.4 million for Q2 2026, down 24.39% on a QoQ basis from $4.5 million in Q1 2026, and down 71.09% year-over-year from $11.7 million in Q2 2025.
Analysis
Polomar Health Services (PMHS) Market Capitalization (2022 - 2026) Analysis & Trends
Polomar Health Services has reported Market Capitalization for 5 years, with the latest figure at $3.4 million in Q2 2026.
- On a quarterly basis, Market Capitalization fell 71.09% year-over-year to $3.4 million in Q2 2026; TTM through Jun 2026 was $3.4 million, a 71.09% decrease from a year earlier, with the FY2025 full-year figure at $22.4 million, up 1057.81% from the prior year.
- Market Capitalization was $3.4 million for Q2 2026 at Polomar Health Services, down from $4.5 million in the prior quarter.
- The five-year high for Market Capitalization was $5.8 billion in Q4 2022, with the low at $1.9 million in Q4 2024.
- Average Market Capitalization over 5 years is $493.0 million, with a median of $20.0 million recorded in 2023.
- The largest YoY upside for Market Capitalization was 3740.62% in 2023 against a maximum downside of 99.7% in 2023.
- Over 5 years, Market Capitalization stood at $5.8 billion in 2022, then sank by 99.7% to $17.6 million in 2023, then plunged by 89.0% to $1.9 million in 2024, then soared by 1057.81% to $22.4 million in 2025, then tumbled by 84.86% to $3.4 million in 2026.
- The last three Market Capitalization figures came in at $3.4 million (Q2 2026), $4.5 million (Q1 2026), and $22.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | Polomar Health Services | 5.66 Mn | 5.48 Mn | 935,916.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.39 Mn |
| Mar 31, 2026 | 4.49 Mn |
| Dec 31, 2025 | 22.42 Mn |
| Sep 30, 2025 | 5.60 Mn |
| Jun 30, 2025 | 11.74 Mn |
| Mar 31, 2025 | 10.79 Mn |
| Dec 31, 2024 | 1.94 Mn |
| Sep 30, 2024 | 37.34 Mn |
| Jun 30, 2024 | 161.52 Mn |
| Mar 31, 2024 | 163.71 Mn |
| Dec 31, 2023 | 17.60 Mn |
| Sep 30, 2023 | 145.15 Mn |
| Jun 30, 2023 | 386.49 Mn |
| Mar 31, 2023 | 1.07 Bn |
| Dec 31, 2022 | 5.84 Bn |
| Sep 30, 2022 | 3.78 Mn |